BioAssays strengthens its R+D+i in animal vaccines development through the “2016 NEOTEC” call.
BioAssays has been funded by the Centro de Desarrollo Tecnológico Industrial (CDTI) through the call “NEOTEC 2016” for R+D+i projects aimed to develop a prophylactic and safe vaccine against the ASFV (African Swine Fever Virus)
Thanks to this project, BioAssays strengthens its trajectory as R+D+i company in Biotechnology.
0